Stay informed with the latest litigation news. Explore now

The Medicines patent opposition analysis

Latest patents of The Medicines New

Explore the latest patents granted to The Medicines, showcasing their recent innovations and technological advancements.

Last updated on: Aug 31, 2025
Patent NumberGrant DateTitleLegal Status

Get instant update for new patents of The Medicines

Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionGranted And Under Opposition

Explore patent oppositions filed by The Medicines against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Further Novel Forms Of Interfering Rna MoleculesATUGENOct 16, 2018
Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICSDec 14, 2017

Explore The Medicines's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5

Top competitors of The Medicines

Top competitors of The Medicines based on patent oppositions.